Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan for atrial fibrillation burden in sick sinus syndrome patients with dual-chamber pacemakers
ChiCTR-TRC-12004443Phase 4Completed
- Sponsor
- Nanjing First Hospital
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of olmesartan in Atrial fibrillation (AFib) and sick sinus syndrome (SSS) (2 arms), sponsored by Nanjing First Hospital. Primary endpoint: Atrial fibrillation load. Started Jan 2013; status: completed.
02
Drugs
olmesartan
03
Conditions
Atrial fibrillation (AFib)sick sinus syndrome (SSS)
Beyond the preview
Go deeper on ChiCTR-TRC-12004443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12004443.